Variant report

Variant	esv3356426
Chromosome Location	chr22:32928545-32929783
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr22:32927917-32928729	HepG2	liver:	n/a	n/a
2	ATF1	chr22:32928229-32928869	K562	blood:	n/a	n/a
3	ATF2	chr22:32927973-32928621	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr22:32928709-32928855	K562	blood:	n/a	n/a
5	BHLHE40	chr22:32929724-32929924	HepG2	liver:	n/a	n/a
6	BHLHE40	chr22:32927917-32929366	K562	blood:	n/a	chr22:32928807-32928820
7	BHLHE40	chr22:32927937-32929019	HepG2	liver:	n/a	chr22:32928807-32928820
8	BHLHE40	chr22:32928708-32928975	HepG2	liver:	n/a	chr22:32928807-32928820
9	BRCA1	chr22:32928577-32928898	Hela-S3	cervix:	n/a	n/a
10	BRCA1	chr22:32928356-32928557	HepG2	liver:	n/a	n/a
11	CCNT2	chr22:32928240-32928931	K562	blood:	n/a	n/a
12	CEBPB	chr22:32929620-32929962	HepG2	liver:	n/a	n/a
13	CEBPB	chr22:32928305-32928688	H1-hESC	embryonic stem cell:	n/a	n/a
14	CEBPB	chr22:32929657-32929924	A549	lung:	n/a	n/a
15	CEBPB	chr22:32928076-32928873	HepG2	liver:	n/a	n/a
16	CEBPB	chr22:32928364-32928693	K562	blood:	n/a	n/a
17	CEBPB	chr22:32929668-32929955	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr22:32929635-32929980	IMR90	lung:	n/a	n/a
19	CEBPB	chr22:32928492-32928898	Hela-S3	cervix:	n/a	n/a
20	CEBPD	chr22:32928312-32928628	K562	blood:	n/a	n/a
21	CHD2	chr22:32928251-32928699	K562	blood:	n/a	n/a
22	CHD2	chr22:32927988-32928878	HepG2	liver:	n/a	n/a
23	CHD2	chr22:32928429-32928969	Hela-S3	cervix:	n/a	n/a
24	CTCF	chr22:32928440-32928590	HFF-Myc	foreskin:	n/a	n/a
25	CUX1	chr22:32928482-32928909	K562	blood:	n/a	n/a
26	E2F6	chr22:32928036-32928980	K562	blood:	n/a	n/a
27	E2F6	chr22:32928550-32928888	K562	blood:	n/a	n/a
28	EBF1	chr22:32928570-32928823	GM12878	blood:	n/a	chr22:32928687-32928698 chr22:32928777-32928786
29	EBF1	chr22:32928552-32928823	GM12878	blood:	n/a	chr22:32928556-32928566 chr22:32928556-32928565 chr22:32928687-32928698 chr22:32928777-32928786
30	EGR1	chr22:32928562-32928878	K562	blood:	n/a	chr22:32928768-32928781 chr22:32928835-32928842
31	EGR1	chr22:32928592-32928938	K562	blood:	n/a	chr22:32928768-32928781 chr22:32928835-32928842
32	ELF1	chr22:32928292-32928681	K562	blood:	n/a	n/a
33	ELK1	chr22:32928647-32928847	Hela-S3	cervix:	n/a	n/a
34	EP300	chr22:32928380-32928923	SK-N-SH_RA	brain:	n/a	n/a
35	EP300	chr22:32927867-32929021	HepG2	liver:	n/a	n/a
36	EP300	chr22:32928473-32928956	SK-N-SH_RA	brain:	n/a	n/a
37	EP300	chr22:32928291-32928893	K562	blood:	n/a	n/a
38	EP300	chr22:32927862-32928833	HepG2	liver:	n/a	n/a
39	EP300	chr22:32928329-32929013	SK-N-SH	brain:	n/a	n/a
40	FOS	chr22:32928538-32928712	MCF10A-Er-Src	breast:	n/a	chr22:32928657-32928667 chr22:32928654-32928665 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928658-32928666
41	FOS	chr22:32928536-32928825	MCF10A-Er-Src	breast:	n/a	chr22:32928657-32928667 chr22:32928654-32928665 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928658-32928666
42	FOS	chr22:32928564-32928810	MCF10A-Er-Src	breast:	n/a	chr22:32928657-32928667 chr22:32928654-32928665 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928658-32928666
43	FOS	chr22:32928564-32928764	MCF10A-Er-Src	breast:	n/a	chr22:32928657-32928667 chr22:32928654-32928665 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928657-32928667 chr22:32928658-32928666
44	GTF2F1	chr22:32928310-32928681	H1-hESC	embryonic stem cell:	n/a	n/a
45	GTF2F1	chr22:32928060-32928896	Hela-S3	cervix:	n/a	n/a
46	HCFC1	chr22:32928220-32928931	K562	blood:	n/a	n/a
47	HDAC2	chr22:32927849-32928964	HepG2	liver:	n/a	chr22:32927984-32927998 chr22:32927979-32927993 chr22:32927983-32927997 chr22:32927982-32927996 chr22:32927981-32927995 chr22:32927985-32927999
48	HEY1	chr22:32927917-32928975	HepG2	liver:	n/a	n/a
49	HEY1	chr22:32929756-32930731	HepG2	liver:	n/a	n/a
50	HEY1	chr22:32927864-32929055	HepG2	liver:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr22:32928792..32930842-chr22:32975300..32976843,2	MCF-7	breast:
2	chr22:32928149..32930709-chr22:33046752..33049031,2	MCF-7	breast:
3	chr22:32928032..32930048-chr6:24682726..24684882,3	MCF-7	breast:
4	chr22:32928085..32929693-chr6:24687618..24690090,2	K562	blood:
5	chr22:32928261..32930206-chr22:32941848..32945247,3	MCF-7	breast:
6	chr22:32927446..32930330-chr22:32933647..32935342,2	MCF-7	breast:
7	chr22:32928103..32930722-chr22:32934980..32936586,2	MCF-7	breast:
8	chr22:32927008..32929585-chr6:24687196..24690090,2	K562	blood:
9	chr22:32922025..32930472-chr22:33196157..33204507,15	MCF-7	breast:
10	chr22:32926743..32929840-chr6:24682818..24685708,4	K562	blood:
11	chr22:32927409..32931156-chr22:32954969..32961432,7	MCF-7	breast:
12	chr22:32924838..32926991-chr22:32927023..32929946,3	MCF-7	breast:

Variant related genes	Relation type
SYN3	TF binding region
ENSG00000112304	chromatin interactions
ENSG00000185666	chromatin interactions
ENSG00000100234	chromatin interactions

Extended variants
information (count: 60 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:60 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs551352585	chr22:32928554-32928555	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs571355449	chr22:32928574-32928575	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs533935778	chr22:32928576-32928577	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs553810493	chr22:32928579-32928580	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs567765382	chr22:32928607-32928608	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs575706699	chr22:32928657-32928658	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs148070563	chr22:32928727-32928728	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs544342932	chr22:32928778-32928779	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs575436173	chr22:32928782-32928783	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs544554989	chr22:32928785-32928786	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs192310620	chr22:32928808-32928809	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs546224290	chr22:32928832-32928833	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs557781502	chr22:32928843-32928844	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs184371240	chr22:32928850-32928851	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs540241700	chr22:32928861-32928862	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs559956437	chr22:32928903-32928904	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs199799228	chr22:32928922-32928923	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs397737420	chr22:32928923-32928924	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs113490189	chr22:32928924-32928925	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs373011318	chr22:32928964-32928965	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs114910745	chr22:32928966-32928967	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs563132465	chr22:32928969-32928970	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs116569202	chr22:32928996-32928997	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs5998530	chr22:32929014-32929015	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs377745442	chr22:32929073-32929074	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs571618215	chr22:32929084-32929085	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs539858310	chr22:32929085-32929086	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs78249807	chr22:32929088-32929089	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs28367024	chr22:32929143-32929144	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs565534362	chr22:32929151-32929152	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs13055961	chr22:32929152-32929153	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs552012878	chr22:32929157-32929158	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs187255739	chr22:32929228-32929229	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs192748368	chr22:32929252-32929253	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs569078483	chr22:32929253-32929254	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs538039119	chr22:32929256-32929257	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs562743172	chr22:32929281-32929282	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs184991053	chr22:32929321-32929322	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs373875339	chr22:32929322-32929323	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs189504075	chr22:32929343-32929344	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs376808895	chr22:32929409-32929410	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs551081132	chr22:32929431-32929432	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs34338211	chr22:32929442-32929443	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs112841021	chr22:32929483-32929484	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs75218871	chr22:32929489-32929490	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs533740381	chr22:32929498-32929499	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs543760657	chr22:32929507-32929508	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs34281326	chr22:32929523-32929524	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs573638922	chr22:32929545-32929546	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs58897867	chr22:32929548-32929549	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Velocardiofacial syndrome	20111667	CNVD
Medulloblastoma	21979893	CNVD
sporadic solitary meningiomas	19589153	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Congenital heart defect	22511896	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Seminomas	18059402	CNVD
Cancer	16751803	CNVD
Metanephric adenoma	20802469	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Metachromatic leukodystrophy	18421352	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	22174824	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
small cell lung cancer	20016488	CNVD
Cancer	21183584	CNVD
Renal cell carcinoma	18765545	CNVD
Schizophrenia	19521646	CNVD
Schizophrenia	18990708	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Hepatocellular carcinoma	16750200	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Autism	19384346	CNVD
Myelofibrosis	22110671	CNVD
muscular dystrophy type 1D	21248746	CNVD
Leukoplakia	24403051	CNVD
Ovarian neoplasms	16753589	CNVD
Deafness	17160897	CNVD
Bipolar disorder	19114987	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD

Chromatin state (count:136 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:32914400-32932000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr22:32923600-32931400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr22:32924200-32932200	Enhancers	Placenta	Placenta
4	chr22:32924400-32930200	Enhancers	Breast Myoepithelial Primary Cells	Breast
5	chr22:32924600-32932000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
6	chr22:32924600-32932800	Enhancers	Fetal Muscle Leg	muscle
7	chr22:32924800-32931000	Enhancers	Skeletal Muscle Female	skeletal muscle
8	chr22:32924800-32931200	Enhancers	Fetal Lung	lung
9	chr22:32924800-32931200	Enhancers	NHDF-Ad	bronchial
10	chr22:32924800-32932200	Enhancers	Fetal Stomach	stomach
11	chr22:32925200-32931000	Enhancers	Rectal Mucosa Donor 31	rectum
12	chr22:32925600-32929600	Weak transcription	Brain Substantia Nigra	brain
13	chr22:32925600-32930600	Weak transcription	Brain Cingulate Gyrus	brain
14	chr22:32925800-32929600	Weak transcription	Liver	Liver
15	chr22:32925800-32929600	Weak transcription	Brain Anterior Caudate	brain
16	chr22:32926800-32930800	Weak transcription	Rectal Mucosa Donor 29	rectum
17	chr22:32926800-32932200	Enhancers	Left Ventricle	heart
18	chr22:32927000-32928600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
19	chr22:32927000-32931000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
20	chr22:32927200-32929200	Enhancers	Rectal Smooth Muscle	rectum
21	chr22:32927200-32929800	Enhancers	Ovary	ovary
22	chr22:32927200-32930800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr22:32927200-32931000	Enhancers	Muscle Satellite Cultured Cells	--
24	chr22:32927200-32931000	Enhancers	Osteobl	bone
25	chr22:32927400-32928600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
26	chr22:32927400-32928600	Enhancers	Fetal Thymus	thymus
27	chr22:32927400-32928800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr22:32927400-32928800	Enhancers	HSMMtube	muscle
29	chr22:32927400-32929400	Enhancers	HMEC	breast
30	chr22:32927400-32929400	Enhancers	HSMM	muscle
31	chr22:32927400-32930000	Enhancers	Fetal Heart	heart
32	chr22:32927400-32930200	Enhancers	Right Atrium	heart
33	chr22:32927400-32930400	Enhancers	Colon Smooth Muscle	Colon
34	chr22:32927400-32930400	Flanking Active TSS	HepG2	liver
35	chr22:32927400-32931000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr22:32927600-32928600	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr22:32927600-32931800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
38	chr22:32927800-32928600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr22:32927800-32928600	Enhancers	Fetal Intestine Large	intestine
40	chr22:32927800-32928800	Enhancers	Duodenum Mucosa	Duodenum
41	chr22:32927800-32930000	Weak transcription	Fetal Kidney	kidney
42	chr22:32927800-32932200	Enhancers	Right Ventricle	heart
43	chr22:32928000-32928600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr22:32928000-32928600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr22:32928000-32928600	Enhancers	Brain Hippocampus Middle	brain
46	chr22:32928000-32928600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
47	chr22:32928000-32928600	Enhancers	Sigmoid Colon	Sigmoid Colon
48	chr22:32928000-32928600	Enhancers	Small Intestine	intestine
49	chr22:32928000-32928600	Enhancers	HUVEC	blood vessel
50	chr22:32928000-32928800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links